/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
ARC Specialties selects Universal Robots as ‘Golden Arm’ in New Artificial Intelligence Pipe Welding System Launching at OTC 2019
ARC Specialties has solved the challenge of creating repeatable full
penetration pipe welds by combining AI, advanced sensors, and the UR5
collaborative robot from Universal Robots. The unique Artificial
Intelligence Pipe Welding System debuts at the Offshore Technology
Conference in Houston, May 6-9.
ANN ARBOR, Mich.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/ARCSpecialties?src=hash” target=”_blank”gt;#ARCSpecialtieslt;/agt;–The toughest welds to make are full penetration, single sided, V butt,
pipe welds. Historically, ARC
Specialties, a Houston-based developer of welding solutions,
declined these jobs because joint fit-up was never repeatable. “Only
human welders with a ‘golden arm’ able to compensate for variation in
root openings, weld center lines, and groove volumes could handle this
challenge,” says Dan Allford, President of ARC Specialties. “With the
industry facing labor shortages, we decided to develop an intelligent
machine with complete knowledge of pipe welding, with full motion and
welding control.”
The Artificial Intelligence Pipe Welding System (AIPW) incorporates the
6-axis UR5
collaborative robot arm from Universal
Robots to carry out the challenging welds. “The UR5 now becomes our
‘golden arm’,” says Allford. “The UR5 is small enough to be portable yet
still allows full freedom of motion for both the laser scanner and
welding torch. Being collaborative the robot is able to safely work in
close proximity to humans.” The AIPW officially launches at ARC
Specialties’ booth
705 at the Offshore Technology Conference held in Houston, TX, May
6-9.
Stuart Shepherd, Regional Sales Director of Universal Robots’ Americas
division, is delighted to see the UR5 power ARC’s AIPW system. “This
implementation underscores our collaborative robots’ ability to handle
heavy-duty processing tasks that demand both high precision and
real-time adaptability,” he says. “We’re excited to share this solution
with the oil and gas industry.”
The AIPW pre-scans the root opening (gap) using a 2D laser, then uses
the data to generate the robot path and welding parameters. Gap
variations are compensated for with changes in oscillation, torch
position, travel speed and welding conditions. The UR5 positions the
torch over a tack weld to start the arc to insure 100% root weld
acceptance. Fill and cap pass programs are optimized to fill the groove
using user selectable weave or stringer bead welding techniques. The
AIPW uses the Miller Auto Continuum welding power supply to weld the
root with Regulated Metal Deposition (RMD), then switches to pulsed
spray for the fill and cap passes. This combination of Gas Metal Arc
Welding techniques maximizes welding productivity while producing X-Ray
quality, full penetration pipe welds.
The AIPW follows two other successful welding solutions featuring
Universal Robots developed by ARC Specialties; the MIG welding SnapWeld
and the plasma cutting SnapCut.
SnapWeld just became the first product ever to win New Equipment
Digest’s Innovation
Award two years in a row.
About Universal Robots
Universal Robots was co-founded in
2005 by the company’s CTO, Esben Østergaard – the 2018 Engelberger Award
Winner – who wanted to make robot technology accessible to all by
developing small, user-friendly, reasonably priced, flexible industrial
robots that are safe to work with. Since the first collaborative robot
(cobot) was launched in 2008, the company has experienced considerable
growth with the user-friendly cobot now sold worldwide. The company,
which is a part of Teradyne Inc., is headquartered in Odense, Denmark,
and has subsidiaries and regional offices in the United States, Germany,
France, Spain, Italy, Czech Republic, Turkey, China, India, Singapore,
Japan, South Korea, Taiwan and Mexico. In 2017, Universal Robots had a
revenue of USD 170 million. For more information, please visit www.universal-robots.com
or read our blog at blog.universal-robots.com.
About ARC Specialties
ARC Specialties was founded in 1983 by
Dan Allford to provide welding services and weld automation to industry.
Since then, ARC Specialties has grown to a 60+ person company occupying
a campus with over 75,000 sq ft. in Houston, TX. These buildings house
all the components for a vertically integrated manufacturing solution
provider: research, design, manufacturing, assembly and testing at a
single location. ARC Specialties has built machines for companies in 21
countries and a variety of industries. The staff includes project
managers, mechanical and electrical designers as well as welders,
electricians and assembly technicians. www.arcspecialties.com
Photos:
Images of AIPW available here: urrobots.com/OTC
Contacts
Company contact:
Joe Campbell
Senior Manager, Strategic
Marketing
& Applications Development
[email protected]
1-844-GO-COBOT
Media contact:
Mette McCall
McCall Media
[email protected]
Tel:
+1 415-847-8649
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493
Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493
Cannabis
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
Cannabis
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
transfer
IMC to transfer its Oranim Pharmacy shares back to the seller
TORONTO and GLIL YAM, Israel, April 16, 2024 /PRNewswire/ — IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the “Company” or “IMC“), a leading medical cannabis company with operations in Israel and Germany, is announcing that, further to the news release dated January 12, 2024, the Company has decided not to make remaining installment payments installments (i.e. NIS 5,873K including interest or 2,154K CAD) by IMC Holdings Ltd., and as such will transfer the 51% shares held by IMC Holdings Ltd back to the seller.
“With the April 1st cannabis legalization in Germany, we are focusing our resources on the German market, where we expect to see the biggest growth potential,” said Oren Shuster, CEO of IMC. “With both of our core markets, Germany and Israel, currently undergoing rapid evolution, we need to assure that we allocate our resources to the growth opportunities where we expect the best return on investment.”
About IM Cannabis Corp.
IMC (Nasdaq: IMCC) (CSE: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company has recently exited operations in Canada to pivot its focus and resources to achieve sustainable and profitable growth in its highest value markets, Israel and Germany. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the Company strives to amplify its commercial and brand power to become a global high-quality cannabis player.
The IMC ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of IMC’s products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. Until recently, the Company also actively operated in Canada through Trichome Financial Corp and its wholly owned subsidiaries, where it cultivated, processed, packaged, and sold premium and ultra-premium cannabis at its own facilities under the WAGNERS and Highland Grow brands for the adult-use market in Canada. The Company has exited operations in Canada and considers these operations discontinued.
Disclaimer for Forward-Looking Statements
This press release contains forward-looking information or forward-looking statements under applicable Canadian and U.S. securities laws (collectively, “forward-looking statements”). All information that addresses activities or developments that we expect to occur in the future are forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as “seek”, “anticipate”, “believe”, “plan”, “estimate”, “expect”, “likely” and “intend” and statements that an event or result “may”, “will”, “should”, “could” or “might” occur or be achieved and other similar expressions. Forward-looking statements are based on the estimates and opinions of management on the date the statements are made. In the press release, such forward-looking statements include, but are not limited to, the occurrence of growth opportunities and the likelihood of growth potential.
Forward-looking statements are based on assumptions that may prove to be incorrect, including but not limited to: the development and introduction of new products; continuing demand for medical and adult-use recreational cannabis in the markets in which the Company operates; the Company’s ability to reach patients through both e-commerce and brick and mortar retail operations; the Company’s ability to maintain and renew or obtain required licenses; the effectiveness of its products for medical cannabis patients and recreational consumers; and the Company’s ability to market its brands and services successfully to its anticipated customers and medical cannabis patients.
The above lists of forward-looking statements and assumptions are not exhaustive. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated or implied by such forward looking statements due to a number of factors and risks. These include: any failure of the Company to maintain “de facto” control over Focus Medical in accordance with IFRS 10; the failure of the Company to comply with applicable regulatory requirements in a highly regulated industry; unexpected changes in governmental policies and regulations in the jurisdictions in which the Company operates; the effect of the reform on the Company; the Company’s ability to continue to meet the listing requirements of the Canadian Securities Exchange and the NASDAQ Capital Market; any unexpected failure to maintain in good standing or renew its licenses; the ability of the Company and Focus Medical (collectively, the “Group”) to deliver on their sales commitments or growth objectives; the reliance of the Group on third-party supply agreements to provide sufficient quantities of medical cannabis to fulfil the Group’s obligations; the Group’s possible exposure to liability, the perceived level of risk related thereto, and the anticipated results of any litigation or other similar disputes or legal proceedings involving the Group; the impact of increasing competition; any lack of merger and acquisition opportunities; adverse market conditions; the inherent uncertainty of production quantities, qualities and cost estimates and the potential for unexpected costs and expenses; risks of product liability and other safety-related liability from the usage of the Group’s cannabis products; supply chain constraints; reliance on key personnel; the risk of defaulting on existing debt and war, conflict and civil unrest in Eastern Europe and the Middle East
Any forward-looking statement included in this press release is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made.
The Company does not undertake any obligation to update forward-looking statements except as required by applicable securities laws. Investors should not place undue reliance on forward-looking statements. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.
Company Contacts:
Anna Taranko, Director Investor & Public Relations
IM Cannabis Corp.
+49 157 80554338
[email protected]
Oren Shuster, Chief Executive Officer
IM Cannabis Corp.
[email protected]
Logo – https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/imc-to-transfer-its-oranim-pharmacy-shares-back-to-the-seller-302117984.html
-
StickIt2 weeks ago
StickIt Technologies Inc. Announces Year-End 2023 Financial Results
-
Cannabis1 week ago
Hemp, Inc. Welcomes USDA Approval of GMO Hemp Strain – A Step Forward in Cannabis Biotechnology
-
Cannabis1 week ago
Right On Brands, Inc. Continues Rollout, Announces 13th Store Opening
-
Cannabis1 week ago
Avicanna Announces Completion of Topical Gel Observational Real-World Evidence Study
-
Cannabis1 week ago
IM Cannabis and Flora Growth Partner to Bring Vessel Cannabis Accessories to the Israeli Market
-
Cannabis1 week ago
Geopulse Exploration, Inc. Acquires 50% of ATC Services
-
Cannabis1 week ago
Tilray Brands, Inc. Reports Q3 Fiscal 2024 Financial Results
-
transfer3 days ago
IMC to transfer its Oranim Pharmacy shares back to the seller